Anthera Pharmaceuticals Inc. (ANTH) OTC MARKETS
$0 0 (0.00%)
Market Cap: $2618
As of 03/28/23 04:00 PM EDT. Market closed.
Anthera Pharmaceuticals Inc. (ANTH)
OTC MARKETS
$0
0 (0.00%)
Market Cap: $2618
As of 03/28/23 04:00 PM EDT. Market closed.
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
J. Craig Thompson
Full Time Employees
21
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
J. Craig Thompson
Full Time Employees
21
URL
Address
25801 Industrial Blvd Ste B, California, Hayward, 94545-2223.
PRICE CHART FOR ANTHERA PHARMACEUTICALS INC
From:
To:
NEWS
KEY STATS
Open
$0
Previous Close
$0
Days Range
$0 - $0
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
3,686
Market Cap
$2618
Dividend Yield
0.00%
P/E
-
Shares Outstanding
26,179,302
Open
$0
Previous Close
$0
Days Range
$0 - $0
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
3,686
Market Cap
$2618
Dividend Yield
0.00%
P/E
-
Shares Outstanding
26,179,302
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ANTHERA PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| THOMPSON JOHN CRAIG | President & CEO | Sep 20, 2017 | Buy | $1.32 | 8,550 | 11,286 | 19,848 | Sep 20, 2017, 07:14 PM |
| TRUEX PAUL F | Director | Sep 07, 2017 | Buy | $1.34 | 5,000 | 6,700 | 16,793 | Sep 07, 2017, 06:56 PM |
| THOMPSON JOHN CRAIG | President & CEO | Sep 07, 2017 | Buy | $1.43 | 10,400 | 14,893 | 11,298 | Sep 07, 2017, 06:56 PM |
| THOMPSON JOHN CRAIG | President & CEO | Sep 07, 2017 | Option Exercise | $1.43 | 10,400 | 14,893 | 17,590 | Sep 07, 2017, 02:43 PM |
| TRUEX PAUL F | Chief Executive Officer | Sep 20, 2016 | Option Exercise | $2.08 | 5,008 | 10,417 | 5,008 | Sep 22, 2016, 07:29 PM |
| Mueller Brian | Director | Dec 23, 2015 | Option Exercise | $2.89 | 10,000 | 28,900 | 10,000 | Dec 24, 2015, 12:35 PM |
| Hislop Colin | Chief Medical Officer | Nov 13, 2015 | Option Exercise | $1.61 | 12,500 | 20,125 | 31,647 | Nov 18, 2015, 06:53 PM |
| Hislop Colin | Chief Medical Officer | Nov 13, 2015 | Sale | $5.31 | 12,500 | 66,341 | 19,147 | Nov 18, 2015, 06:53 PM |
| ODINK DEBRA | Chief Technology Officer | Oct 12, 2015 | Sale | $6.15 | 1,205 | 7,411 | 7,896 | Oct 13, 2015, 08:02 PM |
| TRUEX PAUL F | President and CEO | Jun 30, 2014 | Option Exercise | $3.39 | 699 | 2,370 | 14,709 | Jul 01, 2014, 08:09 PM |
| TRUEX PAUL F | President and CEO | Jun 30, 2014 | Option Exercise | $2.08 | 2,000 | 4,160 | 13,845 | Jul 01, 2014, 08:09 PM |
| TRUEX PAUL F | President and CEO | Jun 30, 2013 | Option Exercise | $3.30 | 6,250 | 20,625 | 80,190 | Mar 28, 2014, 09:23 PM |
| TRUEX PAUL F | President and CEO | Mar 25, 2014 | Option Exercise | $3.30 | 8,974 | 29,614 | 11,845 | Mar 28, 2014, 09:23 PM |
| LIU MAY | Chief Accounting Officer | Mar 25, 2014 | Option Exercise | $3.30 | 529 | 1,746 | 3,677 | Mar 27, 2014, 09:57 PM |
| ODINK DEBRA | Chief Technology Officer | Mar 25, 2014 | Option Exercise | $3.30 | 2,783 | 9,184 | 6,601 | Mar 27, 2014, 09:57 PM |
| TRUEX PAUL F | President and CEO | Mar 25, 2014 | Option Exercise | $3.30 | 6,250 | 20,625 | 597,787 | Mar 27, 2014, 09:56 PM |
| TRUEX PAUL F | President and CEO | Mar 25, 2014 | Option Exercise | $3.30 | 7,622 | 25,153 | 9,333 | Mar 27, 2014, 09:56 PM |
| ODINK DEBRA | Chief Technology Officer | Jun 30, 2013 | Option Exercise | $0.49 | 2,248 | 1,102 | 75,074 | Jul 02, 2013, 09:17 PM |
| LIU MAY | Chief Accounting Officer | Jun 30, 2013 | Option Exercise | $0.49 | 675 | 331 | 33,655 | Jul 02, 2013, 09:17 PM |
| Thompson David E. | Director | Jun 24, 2013 | Buy | $0.53 | 100,000 | 53,000 | 128,201 | Jun 26, 2013, 05:24 PM |
| DZIURZYNSKI BOGDAN | Director | May 31, 2013 | Buy | $0.59 | 10,000 | 5,900 | 10,000 | Jun 04, 2013, 07:26 PM |
| ORBIMED ADVISORS LLC | Director | Jan 30, 2013 | Buy | $0.66 | 5,700,000 | 3,762,000 | 7,462,000 | Feb 01, 2013, 08:19 PM |
| ORBIMED ADVISORS LLC | Director | Jan 25, 2013 | Buy | $0.65 | 1,762,000 | 1,142,481 | 1,762,000 | Jan 29, 2013, 04:54 PM |
| TRUEX PAUL F | President and CEO | Jan 03, 2013 | Option Exercise | $0.69 | 17,454 | 12,043 | 66,412 | Jan 08, 2013, 05:29 PM |
| KILFOIL GEORGINA | SVP,Product Dev.& Project Mgmt | Jan 03, 2013 | Option Exercise | $0.69 | 2,410 | 1,663 | 30,035 | Jan 07, 2013, 09:20 PM |
| ODINK DEBRA | Chief Technology Officer | Jan 03, 2013 | Option Exercise | $0.69 | 3,409 | 2,352 | 31,812 | Jan 07, 2013, 09:18 PM |
| Hislop Colin | Chief Medical Officer | Jan 03, 2013 | Option Exercise | $0.69 | 4,560 | 3,146 | 84,959 | Jan 07, 2013, 09:17 PM |
| LOWE CHRISTOPHER P. | C.F.O. and C.B.O. | Jan 03, 2013 | Option Exercise | $0.69 | 8,660 | 5,975 | 41,336 | Jan 07, 2013, 09:17 PM |
| KILFOIL GEORGINA | SVP,Product Dev.& Project Mgmt | Jun 30, 2012 | Option Exercise | $0.69 | 2,068 | 1,427 | 24,601 | Jul 03, 2012, 07:27 PM |
| ODINK DEBRA | Chief Technology Officer | Jun 30, 2012 | Option Exercise | $0.69 | 1,838 | 1,268 | 24,821 | Jul 03, 2012, 07:27 PM |
| ORBIMED ADVISORS LLC | Director | Jun 29, 2012 | Sale | $0.73 | 1,283,300 | 942,071 | 0 | Jul 03, 2012, 03:19 PM |
| HENNEY CHRISTOPHER S | Director | Jun 29, 2012 | Buy | $0.75 | 100,000 | 74,930 | 100,000 | Jul 02, 2012, 05:46 PM |
| HENNEY CHRISTOPHER S | Director | Jun 29, 2012 | Buy | $0.75 | 100,000 | 74,930 | 202,429 | Jul 02, 2012, 05:46 PM |
| TRUEX PAUL F | President and CEO | Jun 29, 2012 | Buy | $0.76 | 20,000 | 15,200 | 645,125 | Jul 02, 2012, 03:53 PM |
| ORBIMED ADVISORS LLC | Director | Mar 22, 2012 | Sale | $2.40 | 1,306,700 | 3,140,131 | 1,283,300 | Mar 22, 2012, 06:15 PM |
| ORBIMED ADVISORS LLC | Director | Mar 21, 2012 | Sale | $2.87 | 125,000 | 358,312 | 2,590,000 | Mar 22, 2012, 06:15 PM |
| ORBIMED ADVISORS LLC | Director | Mar 20, 2012 | Sale | $2.90 | 116,800 | 338,638 | 2,715,000 | Mar 22, 2012, 06:15 PM |
| ODINK DEBRA | Chief Technology Officer | Mar 01, 2012 | Sale | $6.57 | 2,000 | 13,140 | 26,659 | Mar 05, 2012, 04:01 PM |
| Hislop Colin | Chief Medical Officer | Feb 23, 2012 | Option Exercise | $0.26 | 40,000 | 10,400 | 79,519 | Feb 27, 2012, 05:26 PM |
| TRUEX PAUL F | President and C.E.O. | Feb 15, 2012 | Sale | $7.84 | 15,000 | 117,600 | 625,125 | Feb 17, 2012, 05:15 PM |
| Hislop Colin | Chief Medical Officer | Feb 03, 2012 | Sale | $8.20 | 30,000 | 246,000 | 27,967 | Feb 06, 2012, 08:04 PM |
| LOWE CHRISTOPHER P. | C.F.O. and C.B.O. | Feb 01, 2012 | Sale | $7.66 | 15,000 | 114,900 | 31,151 | Feb 03, 2012, 04:01 PM |
| ODINK DEBRA | Chief Technology Officer | Feb 01, 2012 | Sale | $7.67 | 2,000 | 15,340 | 21,241 | Feb 03, 2012, 04:01 PM |
| TRUEX PAUL F | President and C.E.O. | Jan 31, 2012 | Option Exercise | $0.26 | 20,000 | 5,200 | 640,125 | Feb 02, 2012, 07:37 PM |
| HEALY JAMES | Director | Jan 28, 2012 | Option Exercise | $4.19 | 12,000 | 50,280 | 32,443 | Jan 31, 2012, 05:53 PM |
| TRUEX PAUL F | President and Chief Executive | Jan 17, 2012 | Sale | $6.75 | 15,000 | 101,250 | 627,125 | Jan 19, 2012, 05:03 PM |
| ODINK DEBRA | Chief Technology Officer | Jan 10, 2012 | Sale | $6.51 | 800 | 5,205 | 23,241 | Jan 12, 2012, 12:58 PM |
| ODINK DEBRA | Chief Technology Officer | Jan 06, 2012 | Sale | $6.50 | 1,200 | 7,800 | 24,441 | Jan 10, 2012, 02:27 PM |
| HEALY JAMES | Director | Dec 30, 2011 | Sale | $6.22 | 25,000 | 155,625 | 3,298,684 | Jan 03, 2012, 08:31 PM |
| SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | Dec 30, 2011 | Sale | $6.22 | 25,000 | 155,625 | 3,298,684 | Jan 03, 2012, 08:31 PM |
| HEALY JAMES | Director | Dec 22, 2011 | Sale | $6.22 | 25,000 | 155,605 | 3,319,314 | Dec 23, 2011, 06:22 PM |
| HEALY JAMES | Director | Dec 21, 2011 | Sale | $6.51 | 25,000 | 162,770 | 3,339,944 | Dec 23, 2011, 06:22 PM |
| SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | Dec 22, 2011 | Sale | $6.22 | 25,000 | 155,605 | 3,319,314 | Dec 23, 2011, 06:22 PM |
| SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | Dec 21, 2011 | Sale | $6.51 | 25,000 | 162,770 | 3,339,944 | Dec 23, 2011, 06:22 PM |
| SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | Mar 04, 2010 | Option Exercise | $6.75 | 1,253,635 | 8,462,757 | 3,360,574 | Dec 22, 2011, 06:24 PM |
| SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | Mar 04, 2010 | Option Exercise | $5.53 | 741,215 | 4,097,698 | 2,326,015 | Dec 22, 2011, 06:24 PM |
| TRUEX PAUL F | President and CEO | Dec 15, 2011 | Sale | $6.34 | 15,000 | 95,065 | 642,125 | Dec 16, 2011, 09:53 PM |
| ORBIMED ADVISORS LLC | Director | Dec 13, 2011 | Sale | $6.50 | 16,200 | 105,300 | 2,831,800 | Dec 13, 2011, 06:37 PM |
| ORBIMED ADVISORS LLC | Director | Dec 09, 2011 | Sale | $6.75 | 40,000 | 270,000 | 2,848,000 | Dec 13, 2011, 06:37 PM |
| ORBIMED ADVISORS LLC | Director | Nov 16, 2011 | Sale | $6.87 | 25,000 | 171,750 | 2,915,000 | Nov 18, 2011, 05:57 PM |
| ORBIMED ADVISORS LLC | Director | Nov 18, 2011 | Sale | $6.50 | 3,000 | 19,500 | 2,888,000 | Nov 18, 2011, 05:57 PM |
| ORBIMED ADVISORS LLC | Director | Nov 17, 2011 | Sale | $6.67 | 24,000 | 160,080 | 2,891,000 | Nov 18, 2011, 05:57 PM |
| TRUEX PAUL F | President and CEO | Nov 15, 2011 | Sale | $6.96 | 30,000 | 208,704 | 672,125 | Nov 17, 2011, 04:01 PM |
| ORBIMED ADVISORS LLC | Director | Nov 11, 2011 | Sale | $7.14 | 5,000 | 35,700 | 2,995,000 | Nov 15, 2011, 06:29 PM |
| ORBIMED ADVISORS LLC | Director | Nov 15, 2011 | Sale | $6.93 | 50,000 | 346,500 | 2,940,000 | Nov 15, 2011, 06:29 PM |
| ORBIMED ADVISORS LLC | Director | Nov 14, 2011 | Sale | $6.95 | 5,000 | 34,750 | 2,990,000 | Nov 15, 2011, 06:29 PM |
| Hislop Colin | Chief Medical Officer | Nov 08, 2011 | Option Exercise | $0.26 | 15,000 | 3,900 | 72,967 | Nov 10, 2011, 05:06 PM |
| Hislop Colin | Chief Medical Officer | Nov 08, 2011 | Sale | $6.74 | 15,000 | 101,163 | 57,967 | Nov 10, 2011, 05:06 PM |
| LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | Nov 03, 2011 | Sale | $6.88 | 15,000 | 103,236 | 46,151 | Nov 04, 2011, 08:24 PM |
| LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | Oct 25, 2011 | Sale | $7.07 | 4,637 | 32,784 | 0 | Oct 27, 2011, 07:48 PM |
| TRUEX PAUL F | President and CEO | Oct 21, 2011 | Sale | $6.25 | 23,235 | 145,219 | 649,004 | Oct 25, 2011, 09:55 PM |
| TRUEX PAUL F | President and CEO | Oct 18, 2011 | Sale | $6.25 | 6,745 | 42,156 | 660,360 | Oct 20, 2011, 09:28 PM |
| LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | Aug 08, 2011 | Option Exercise | $1.34 | 10,000 | 13,400 | 61,151 | Aug 09, 2011, 06:21 PM |
| TRUEX PAUL F | President and CEO | Aug 08, 2011 | Option Exercise | $0.26 | 50,000 | 13,000 | 90,512 | Aug 09, 2011, 06:16 PM |
| LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | Aug 03, 2011 | Sale | $6.88 | 14,600 | 100,432 | 51,151 | Aug 04, 2011, 08:08 PM |
| LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | Aug 02, 2011 | Sale | $7.31 | 5,000 | 36,571 | 4,937 | Aug 04, 2011, 08:08 PM |
| TRUEX PAUL F | President and CEO | Jul 15, 2011 | Sale | $7.95 | 15,000 | 119,258 | 667,125 | Jul 18, 2011, 05:40 PM |
| Hislop Colin | Chief Medical Officer | Jul 12, 2011 | Option Exercise | $0.26 | 15,000 | 3,900 | 57,967 | Jul 14, 2011, 04:15 PM |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | Jul 07, 2011 | Option Exercise | $2.42 | 19,563 | 47,264 | 5,357,528 | Jul 11, 2011, 05:49 PM |
| TRUEX PAUL F | President and CEO | Jun 30, 2011 | Option Exercise | $8.17 | 48,500 | 396,245 | 40,512 | Jul 05, 2011, 06:37 PM |
| LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | Jun 30, 2011 | Option Exercise | $8.17 | 23,500 | 191,995 | 65,751 | Jul 05, 2011, 06:34 PM |
| KILFOIL GEORGINA | SVP, Prod. Dev. & Project Mngm | Jun 30, 2011 | Option Exercise | $8.17 | 5,625 | 45,956 | 16,875 | Jul 05, 2011, 06:31 PM |
| Hislop Colin | Chief Medical Officer | Jun 30, 2011 | Option Exercise | $8.17 | 17,500 | 142,975 | 42,967 | Jul 05, 2011, 06:28 PM |
| ODINK DEBRA | VP, Pharmaceutical R&D | Jun 30, 2011 | Option Exercise | $8.17 | 3,670 | 29,984 | 25,641 | Jul 05, 2011, 06:23 PM |
| Hislop Colin | Chief Medical Officer | Jun 29, 2011 | Option Exercise | $0.26 | 10,000 | 2,600 | 60,062 | Jun 30, 2011, 08:06 PM |
| LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | Jun 21, 2011 | Option Exercise | $1.31 | 20,000 | 26,200 | 87,645 | Jun 22, 2011, 08:11 PM |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | Jun 16, 2011 | Sale | $8.67 | 3,100 | 26,877 | 4,836,202 | Jun 20, 2011, 05:46 PM |
| TRUEX PAUL F | President and CEO | Jun 15, 2011 | Sale | $8.30 | 15,000 | 124,539 | 682,125 | Jun 17, 2011, 07:50 PM |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | Jun 14, 2011 | Sale | $8.81 | 699 | 6,158 | 4,839,011 | Jun 15, 2011, 08:21 PM |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | Jun 13, 2011 | Sale | $8.80 | 1,300 | 11,440 | 4,839,645 | Jun 15, 2011, 08:21 PM |
| ORBIMED ADVISORS LLC | Director | Jun 10, 2011 | Sale | $8.18 | 30,000 | 245,400 | 3,000,000 | Jun 10, 2011, 06:28 PM |
| ORBIMED ADVISORS LLC | Director | Jun 09, 2011 | Sale | $8.11 | 37,000 | 300,070 | 3,030,000 | Jun 10, 2011, 06:28 PM |
| ORBIMED ADVISORS LLC | Director | Jun 08, 2011 | Sale | $8.02 | 33,000 | 264,660 | 3,067,000 | Jun 10, 2011, 06:28 PM |
| ORBIMED ADVISORS LLC | Director | May 18, 2011 | Sale | $8.03 | 69,334 | 556,752 | 3,139,000 | Jun 06, 2011, 06:19 AM |
| ORBIMED ADVISORS LLC | Director | May 17, 2011 | Sale | $8.32 | 100,000 | 832,000 | 3,208,334 | Jun 06, 2011, 06:19 AM |
| ORBIMED ADVISORS LLC | Director | May 16, 2011 | Sale | $7.20 | 12,000 | 86,400 | 3,308,334 | Jun 06, 2011, 06:19 AM |
| ORBIMED ADVISORS LLC | Director | May 11, 2011 | Sale | $7.22 | 13,000 | 93,860 | 3,320,334 | Jun 06, 2011, 06:16 AM |
| ORBIMED ADVISORS LLC | Director | May 10, 2011 | Sale | $7.23 | 106,400 | 769,272 | 3,333,334 | Jun 06, 2011, 06:16 AM |
| ORBIMED ADVISORS LLC | Director | May 09, 2011 | Sale | $7.26 | 10,000 | 72,600 | 3,439,734 | Jun 06, 2011, 06:16 AM |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | May 26, 2011 | Sale | $8.60 | 4,800 | 41,280 | 4,840,823 | May 31, 2011, 07:31 PM |
| ORBIMED ADVISORS LLC | Director | May 26, 2011 | Sale | $8.53 | 34,200 | 291,726 | 3,100,000 | May 27, 2011, 06:58 PM |
| ORBIMED ADVISORS LLC | Director | May 25, 2011 | Sale | $8.65 | 4,800 | 41,520 | 3,134,200 | May 27, 2011, 06:58 PM |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | May 25, 2011 | Sale | $8.67 | 32,750 | 283,943 | 4,845,172 | May 25, 2011, 06:42 PM |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | May 24, 2011 | Sale | $8.42 | 52,196 | 439,490 | 4,874,844 | May 25, 2011, 06:42 PM |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | May 23, 2011 | Sale | $8.18 | 26,703 | 218,431 | 4,922,134 | May 25, 2011, 06:42 PM |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | May 17, 2011 | Sale | $8.29 | 13,900 | 115,231 | 5,059,578 | May 19, 2011, 06:23 PM |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | May 19, 2011 | Sale | $8.03 | 125,000 | 1,003,750 | 4,946,327 | May 19, 2011, 06:23 PM |
| TRUEX PAUL F | President and CEO | May 16, 2011 | Sale | $7.16 | 15,000 | 107,339 | 692,003 | May 18, 2011, 07:28 PM |
| ORBIMED ADVISORS LLC | Director | May 18, 2011 | Sale | $8.03 | 69,334 | 556,752 | 3,139,000 | May 18, 2011, 07:12 PM |
| ORBIMED ADVISORS LLC | Director | May 17, 2011 | Sale | $8.32 | 100,000 | 832,000 | 3,208,334 | May 18, 2011, 07:12 PM |
| ORBIMED ADVISORS LLC | Director | May 16, 2011 | Sale | $7.20 | 12,000 | 86,400 | 3,308,334 | May 18, 2011, 07:12 PM |
| ORBIMED ADVISORS LLC | Director | May 10, 2011 | Sale | $7.23 | 106,400 | 769,272 | 3,333,334 | May 11, 2011, 08:21 PM |
| ORBIMED ADVISORS LLC | Director | May 09, 2011 | Sale | $7.26 | 10,000 | 72,600 | 3,439,734 | May 11, 2011, 08:21 PM |
| ORBIMED ADVISORS LLC | Director | May 11, 2011 | Sale | $7.22 | 13,000 | 93,860 | 3,320,334 | May 11, 2011, 08:21 PM |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | May 05, 2011 | Sale | $7.01 | 387,700 | 2,717,777 | 5,072,171 | May 05, 2011, 05:36 PM |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | May 04, 2011 | Sale | $7.00 | 200,000 | 1,400,000 | 5,423,428 | May 05, 2011, 05:36 PM |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | May 03, 2011 | Sale | $7.00 | 100,000 | 700,000 | 5,604,628 | May 05, 2011, 05:36 PM |
| ODINK DEBRA | VP, Pharmaceutical R&D | Apr 13, 2011 | Option Exercise | $1.51 | 3,311 | 5,000 | 29,311 | Apr 14, 2011, 08:36 PM |
| TRUEX PAUL F | President and CEO | Apr 13, 2011 | Option Exercise | $0.26 | 30,000 | 7,800 | 121,122 | Apr 14, 2011, 08:35 PM |
| Thompson David E. | Director | Jan 03, 2011 | Option Exercise | $1.39 | 11,558 | 16,067 | 11,558 | Jan 05, 2011, 08:50 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Sep 30, 2010 | Buy | $4.08 | 19,900 | 81,192 | 3,449,734 | Oct 04, 2010, 08:08 PM |
| ODINK DEBRA | VP, Pharmaceutical R&D | Sep 24, 2010 | Buy | $4.20 | 1,000 | 4,200 | 26,000 | Sep 24, 2010, 09:22 PM |
| LOWE CHRISTOPHER P. | CFO & VP of Administration | Sep 24, 2010 | Buy | $4.18 | 5,000 | 20,900 | 62,523 | Sep 24, 2010, 09:20 PM |
| Leheny A. Rachel | Director | Sep 24, 2010 | Buy | $3.00 | 250,000 | 750,000 | 1,423,896 | Sep 24, 2010, 09:19 PM |
| Trias Joaquim | Sr. VP, Preclinical Developmen | Sep 21, 2010 | Option Exercise | $1.51 | 4,380 | 6,614 | 198,546 | Sep 23, 2010, 08:44 PM |
| Hislop Colin | Sr. VP, Cardiovasc. Prod. | Sep 21, 2010 | Option Exercise | $0.26 | 14,683 | 3,818 | 15,183 | Sep 23, 2010, 08:40 PM |
| Hislop Colin | Sr. VP, Cardiovasc. Prod. | Aug 18, 2010 | Buy | $4.80 | 500 | 2,400 | 500 | Aug 20, 2010, 02:37 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| THOMPSON JOHN CRAIG | President & CEO | 09/20/2017 | 11,286 |
| TRUEX PAUL F | Director | 09/07/2017 | 6,700 |
| THOMPSON JOHN CRAIG | President & CEO | 09/07/2017 | 14,893 |
| THOMPSON JOHN CRAIG | President & CEO | 09/07/2017 | 14,893 |
| TRUEX PAUL F | Chief Executive Officer | 09/20/2016 | 10,417 |
| Mueller Brian | Director | 12/23/2015 | 28,900 |
| Hislop Colin | Chief Medical Officer | 11/13/2015 | 20,125 |
| Hislop Colin | Chief Medical Officer | 11/13/2015 | 66,341 |
| ODINK DEBRA | Chief Technology Officer | 10/12/2015 | 7,411 |
| TRUEX PAUL F | President and CEO | 06/30/2014 | 2,370 |
| TRUEX PAUL F | President and CEO | 06/30/2014 | 4,160 |
| TRUEX PAUL F | President and CEO | 06/30/2013 | 20,625 |
| TRUEX PAUL F | President and CEO | 03/25/2014 | 29,614 |
| LIU MAY | Chief Accounting Officer | 03/25/2014 | 1,746 |
| ODINK DEBRA | Chief Technology Officer | 03/25/2014 | 9,184 |
| TRUEX PAUL F | President and CEO | 03/25/2014 | 20,625 |
| TRUEX PAUL F | President and CEO | 03/25/2014 | 25,153 |
| ODINK DEBRA | Chief Technology Officer | 06/30/2013 | 1,102 |
| LIU MAY | Chief Accounting Officer | 06/30/2013 | 331 |
| Thompson David E. | Director | 06/24/2013 | 53,000 |
| DZIURZYNSKI BOGDAN | Director | 05/31/2013 | 5,900 |
| ORBIMED ADVISORS LLC | Director | 01/30/2013 | 3,762,000 |
| ORBIMED ADVISORS LLC | Director | 01/25/2013 | 1,142,481 |
| TRUEX PAUL F | President and CEO | 01/03/2013 | 12,043 |
| KILFOIL GEORGINA | SVP,Product Dev.& Project Mgmt | 01/03/2013 | 1,663 |
| ODINK DEBRA | Chief Technology Officer | 01/03/2013 | 2,352 |
| Hislop Colin | Chief Medical Officer | 01/03/2013 | 3,146 |
| LOWE CHRISTOPHER P. | C.F.O. and C.B.O. | 01/03/2013 | 5,975 |
| KILFOIL GEORGINA | SVP,Product Dev.& Project Mgmt | 06/30/2012 | 1,427 |
| ODINK DEBRA | Chief Technology Officer | 06/30/2012 | 1,268 |
| ORBIMED ADVISORS LLC | Director | 06/29/2012 | 942,071 |
| HENNEY CHRISTOPHER S | Director | 06/29/2012 | 74,930 |
| HENNEY CHRISTOPHER S | Director | 06/29/2012 | 74,930 |
| TRUEX PAUL F | President and CEO | 06/29/2012 | 15,200 |
| ORBIMED ADVISORS LLC | Director | 03/22/2012 | 3,140,131 |
| ORBIMED ADVISORS LLC | Director | 03/21/2012 | 358,312 |
| ORBIMED ADVISORS LLC | Director | 03/20/2012 | 338,638 |
| ODINK DEBRA | Chief Technology Officer | 03/01/2012 | 13,140 |
| Hislop Colin | Chief Medical Officer | 02/23/2012 | 10,400 |
| TRUEX PAUL F | President and C.E.O. | 02/15/2012 | 117,600 |
| Hislop Colin | Chief Medical Officer | 02/03/2012 | 246,000 |
| LOWE CHRISTOPHER P. | C.F.O. and C.B.O. | 02/01/2012 | 114,900 |
| ODINK DEBRA | Chief Technology Officer | 02/01/2012 | 15,340 |
| TRUEX PAUL F | President and C.E.O. | 01/31/2012 | 5,200 |
| HEALY JAMES | Director | 01/28/2012 | 50,280 |
| TRUEX PAUL F | President and Chief Executive | 01/17/2012 | 101,250 |
| ODINK DEBRA | Chief Technology Officer | 01/10/2012 | 5,205 |
| ODINK DEBRA | Chief Technology Officer | 01/06/2012 | 7,800 |
| HEALY JAMES | Director | 12/30/2011 | 155,625 |
| SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | 12/30/2011 | 155,625 |
| HEALY JAMES | Director | 12/22/2011 | 155,605 |
| HEALY JAMES | Director | 12/21/2011 | 162,770 |
| SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | 12/22/2011 | 155,605 |
| SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | 12/21/2011 | 162,770 |
| SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | 03/04/2010 | 8,462,757 |
| SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | 03/04/2010 | 4,097,698 |
| TRUEX PAUL F | President and CEO | 12/15/2011 | 95,065 |
| ORBIMED ADVISORS LLC | Director | 12/13/2011 | 105,300 |
| ORBIMED ADVISORS LLC | Director | 12/09/2011 | 270,000 |
| ORBIMED ADVISORS LLC | Director | 11/16/2011 | 171,750 |
| ORBIMED ADVISORS LLC | Director | 11/18/2011 | 19,500 |
| ORBIMED ADVISORS LLC | Director | 11/17/2011 | 160,080 |
| TRUEX PAUL F | President and CEO | 11/15/2011 | 208,704 |
| ORBIMED ADVISORS LLC | Director | 11/11/2011 | 35,700 |
| ORBIMED ADVISORS LLC | Director | 11/15/2011 | 346,500 |
| ORBIMED ADVISORS LLC | Director | 11/14/2011 | 34,750 |
| Hislop Colin | Chief Medical Officer | 11/08/2011 | 3,900 |
| Hislop Colin | Chief Medical Officer | 11/08/2011 | 101,163 |
| LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | 11/03/2011 | 103,236 |
| LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | 10/25/2011 | 32,784 |
| TRUEX PAUL F | President and CEO | 10/21/2011 | 145,219 |
| TRUEX PAUL F | President and CEO | 10/18/2011 | 42,156 |
| LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | 08/08/2011 | 13,400 |
| TRUEX PAUL F | President and CEO | 08/08/2011 | 13,000 |
| LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | 08/03/2011 | 100,432 |
| LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | 08/02/2011 | 36,571 |
| TRUEX PAUL F | President and CEO | 07/15/2011 | 119,258 |
| Hislop Colin | Chief Medical Officer | 07/12/2011 | 3,900 |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 07/07/2011 | 47,264 |
| TRUEX PAUL F | President and CEO | 06/30/2011 | 396,245 |
| LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | 06/30/2011 | 191,995 |
| KILFOIL GEORGINA | SVP, Prod. Dev. & Project Mngm | 06/30/2011 | 45,956 |
| Hislop Colin | Chief Medical Officer | 06/30/2011 | 142,975 |
| ODINK DEBRA | VP, Pharmaceutical R&D | 06/30/2011 | 29,984 |
| Hislop Colin | Chief Medical Officer | 06/29/2011 | 2,600 |
| LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | 06/21/2011 | 26,200 |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 06/16/2011 | 26,877 |
| TRUEX PAUL F | President and CEO | 06/15/2011 | 124,539 |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 06/14/2011 | 6,158 |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 06/13/2011 | 11,440 |
| ORBIMED ADVISORS LLC | Director | 06/10/2011 | 245,400 |
| ORBIMED ADVISORS LLC | Director | 06/09/2011 | 300,070 |
| ORBIMED ADVISORS LLC | Director | 06/08/2011 | 264,660 |
| ORBIMED ADVISORS LLC | Director | 05/18/2011 | 556,752 |
| ORBIMED ADVISORS LLC | Director | 05/17/2011 | 832,000 |
| ORBIMED ADVISORS LLC | Director | 05/16/2011 | 86,400 |
| ORBIMED ADVISORS LLC | Director | 05/11/2011 | 93,860 |
| ORBIMED ADVISORS LLC | Director | 05/10/2011 | 769,272 |
| ORBIMED ADVISORS LLC | Director | 05/09/2011 | 72,600 |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 05/26/2011 | 41,280 |
| ORBIMED ADVISORS LLC | Director | 05/26/2011 | 291,726 |
| ORBIMED ADVISORS LLC | Director | 05/25/2011 | 41,520 |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 05/25/2011 | 283,943 |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 05/24/2011 | 439,490 |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 05/23/2011 | 218,431 |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 05/17/2011 | 115,231 |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 05/19/2011 | 1,003,750 |
| TRUEX PAUL F | President and CEO | 05/16/2011 | 107,339 |
| ORBIMED ADVISORS LLC | Director | 05/18/2011 | 556,752 |
| ORBIMED ADVISORS LLC | Director | 05/17/2011 | 832,000 |
| ORBIMED ADVISORS LLC | Director | 05/16/2011 | 86,400 |
| ORBIMED ADVISORS LLC | Director | 05/10/2011 | 769,272 |
| ORBIMED ADVISORS LLC | Director | 05/09/2011 | 72,600 |
| ORBIMED ADVISORS LLC | Director | 05/11/2011 | 93,860 |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 05/05/2011 | 2,717,777 |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 05/04/2011 | 1,400,000 |
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 05/03/2011 | 700,000 |
| ODINK DEBRA | VP, Pharmaceutical R&D | 04/13/2011 | 5,000 |
| TRUEX PAUL F | President and CEO | 04/13/2011 | 7,800 |
| Thompson David E. | Director | 01/03/2011 | 16,067 |
| ORBIMED ADVISORS LLC | 10% Owner | 09/30/2010 | 81,192 |
| ODINK DEBRA | VP, Pharmaceutical R&D | 09/24/2010 | 4,200 |
| LOWE CHRISTOPHER P. | CFO & VP of Administration | 09/24/2010 | 20,900 |
| Leheny A. Rachel | Director | 09/24/2010 | 750,000 |
| Trias Joaquim | Sr. VP, Preclinical Developmen | 09/21/2010 | 6,614 |
| Hislop Colin | Sr. VP, Cardiovasc. Prod. | 09/21/2010 | 3,818 |
| Hislop Colin | Sr. VP, Cardiovasc. Prod. | 08/18/2010 | 2,400 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR ANTHERA PHARMACEUTICALS INC
STOCK BUYBACKS FOR ANTHERA PHARMACEUTICALS INC
Load More
Period of Report: 03/31/2018
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2016
-46.34%
5Q
09/30/2016
-45.83%
6Q
06/30/2016
-45.32%
7Q
03/31/2016
-44.65%
8Q
12/31/2015
-37.79%
9Q
Load More